Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Aug 17, 2017 10:48am
195 Views
Post# 26591652

RE:RE:RE:RE:Let's call a spade a spade

RE:RE:RE:RE:Let's call a spade a spadeThank you again Eric.  You have cleared up several items for me.  Really a terrific post.!  I would also like to agree with you on the disarray of the FDA under new leadership. While changes are not a bad thing, Prometic has had the bad luck to get slowed up because of these changes. I have been reading various FDA articles and it is an eye opener.  For example:  some in the FDA  don't want to have the Pediatric voucher because it can be sold etc. etc. The overhaul of the FDA and their policies is going to take time.
Bullboard Posts